Wells Fargo
EVGN icon

Wells Fargo’s Evogene EVGN Stock Holding History

Wells Fargo’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16
Closed – – 6980
2022
Q1 		$0 Buy
+16
New +$216 ﹤0.01% 7249
2021
Q4 		– Sell
-290
Closed -$6.58K – 7363
2021
Q3 		$8K Sell
290
-505
-64% -$14.7K ﹤0.01% 6269
2021
Q2 		$27K Buy
795
+495
+165% +$19.4K ﹤0.01% 5791
2021
Q1 		$15K Sell
300
-3,172
-91% -$196K ﹤0.01% 6231
2020
Q4 		$163K Buy
3,472
+1,000
+40% +$35.3K ﹤0.01% 5165
2020
Q3 		$98K Sell
2,472
-3,848
-61% -$68.7K ﹤0.01% 5276
2020
Q2 		$63K Buy
6,320
+4,620
+272% +$50.1K ﹤0.01% 5414
2020
Q1 		$20K Buy
+1,700
New +$23.4K ﹤0.01% 5601
2017
Q3 		– Sell
-100
Closed -$5K – 6348
2017
Q2 		$5K Hold
100
– – ﹤0.01% 5913
2017
Q1 		$5K Hold
100
– – ﹤0.01% 6020
2016
Q4 		$5K Hold
100
– – ﹤0.01% 5950
2016
Q3 		$6K Hold
100
– – ﹤0.01% 5865
2016
Q2 		$6K Hold
100
– – ﹤0.01% 5779
2016
Q1 		$7K Hold
100
– – ﹤0.01% 5798
2015
Q4 		$8K Hold
100
– – ﹤0.01% 5787
2015
Q3 		$8K Sell
100
-100
-50% -$8.71K ﹤0.01% 5751
2015
Q2 		$18K Buy
+200
New +$19.4K ﹤0.01% 5630
2014
Q3 		– Sell
-20
Closed -$3K – 6213
2014
Q2 		$3K Sell
20
-40
-67% -$6.88K ﹤0.01% 5883
2014
Q1 		$11K Sell
60
-148
-71% -$28K ﹤0.01% 5376
2013
Q4 		$41K Buy
+208
New +$38.4K ﹤0.01% 4804

Other funds holding EVGN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return

Wells Fargo's EVGN Position: Q2 2022 in Review

Wells Fargo sold out of Evogene (EVGN) in Q2 2022, closing a stake of 16 shares.

Wells Fargo first reported a position in EVGN in Q4 2013 and held it in 20 quarters. The position peaked at $163K in Q4 2020. 29 funds tracked by Wall St. Rank hold EVGN as of Q2 2022.

  • Wells Fargo reported no remaining Evogene position as of Q2 2022 after selling out during the quarter.
  • Wells Fargo sold 16 Evogene shares in Q2 2022.
  • Wells Fargo first reported a position in Evogene in Q4 2013 and held it in 20 quarters.
  • Wells Fargo's Evogene position peaked at $163K in Q4 2020.
  • 29 funds tracked by Wall St. Rank held Evogene as of Q2 2022.

Based on Wells Fargo's 13F filing for Q2 2022, filed 12 Aug 2022.